Bank of Nova Scotia lessened its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 69.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 16,396 shares of the semiconductor company’s stock after selling 36,579 shares during the quarter. Bank of Nova Scotia’s holdings in Synopsys were worth $8,406,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of SNPS. Lionshead Wealth Management LLC lifted its stake in shares of Synopsys by 1.9% during the 2nd quarter. Lionshead Wealth Management LLC now owns 914 shares of the semiconductor company’s stock worth $469,000 after buying an additional 17 shares during the last quarter. YANKCOM Partnership lifted its position in Synopsys by 3.3% during the second quarter. YANKCOM Partnership now owns 537 shares of the semiconductor company’s stock worth $275,000 after acquiring an additional 17 shares during the last quarter. Manchester Capital Management LLC boosted its holdings in shares of Synopsys by 5.3% during the second quarter. Manchester Capital Management LLC now owns 340 shares of the semiconductor company’s stock worth $174,000 after acquiring an additional 17 shares during the period. Hemington Wealth Management grew its position in shares of Synopsys by 10.1% in the second quarter. Hemington Wealth Management now owns 197 shares of the semiconductor company’s stock valued at $100,000 after purchasing an additional 18 shares during the last quarter. Finally, Concord Asset Management LLC VA increased its stake in shares of Synopsys by 0.8% during the second quarter. Concord Asset Management LLC VA now owns 2,379 shares of the semiconductor company’s stock worth $1,220,000 after purchasing an additional 18 shares during the period. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
SNPS has been the subject of several recent research reports. Mizuho reduced their price target on Synopsys from $700.00 to $600.00 and set an “outperform” rating for the company in a research note on Thursday, September 11th. KeyCorp dropped their target price on Synopsys from $590.00 to $575.00 and set an “overweight” rating for the company in a report on Wednesday, December 3rd. Zacks Research raised shares of Synopsys from a “strong sell” rating to a “hold” rating in a research report on Monday, November 10th. Weiss Ratings restated a “hold (c)” rating on shares of Synopsys in a research note on Wednesday, October 8th. Finally, Wall Street Zen cut shares of Synopsys from a “hold” rating to a “sell” rating in a research note on Saturday, September 13th. Eleven research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $550.67.
Insider Buying and Selling
In other news, CAO Sudhindra Kankanwadi sold 9,873 shares of the stock in a transaction dated Monday, September 22nd. The shares were sold at an average price of $500.90, for a total value of $4,945,385.70. Following the completion of the transaction, the chief accounting officer owned 20,520 shares of the company’s stock, valued at approximately $10,278,468. This represents a 32.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.62% of the company’s stock.
Synopsys Stock Up 2.1%
Shares of SNPS opened at $475.83 on Thursday. The firm has a 50 day simple moving average of $435.91 and a two-hundred day simple moving average of $504.68. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.62 and a quick ratio of 1.51. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73. The company has a market cap of $88.39 billion, a P/E ratio of 37.35, a P/E/G ratio of 5.78 and a beta of 1.16.
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, beating analysts’ consensus estimates of $2.79 by $0.11. Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The firm had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same quarter last year, the business posted $3.40 EPS. The company’s revenue was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Research analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.
Synopsys Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles
- Five stocks we like better than Synopsys
- 3 REITs to Buy and Hold for the Long Term
- Market Momentum: 3 Stocks Poised for Major Breakouts
- 3 Warren Buffett Stocks to Buy Now
- 3 Reasons Casey’s General Stores Will Continue Trending Higher
- What is an Earnings Surprise?
- Golden Cross Alert: 3 Stocks With Major Upside Potential
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
